Advertisement

Quality of life after peritoneal dialysis

  • T. Apostolou
  • R. Gokal

Abstract

Interest in measuring quality of life in relation to health care has increased enormously [1, 2], and in the past two decades has emerged as an important attribute of clinical investigation and patient care [3]. Moreover, quality of life assessments are increasingly recognized as a major endpoint for phase III randomized controlled trials. Several clinical trial organizations have now introduced the notion of quality of life as a standard part of new trials. In the UK the Medical Research Councilfunded trials in general are expected either to assess the impact of every new trial on quality of life or to justify not doing so [4, 5]. Just as introducing evidence-based medicine into clinical practice gathers momentum, so do quality of life assessments, which have to be considered against any gains in therapeutic efficacy resulting from current or new treatments.

Keywords

Life Satisfaction Peritoneal Dialysis Dialysis Patient ESRD Patient Sickness Impact Profile 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Spilker B, Molinek F, Jhnston K, Simpson RL, Tilson HH. Quality of life bibliography and indexes. Med Care 1990; 28 (suppl.): D51–77.Google Scholar
  2. 2.
    Wilkin D, Hallam L, Doggett M. Measure of Need and Outcome for Primary Care. Oxford: Oxford University Press, 1992.Google Scholar
  3. 3.
    Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int 1993; 43 (suppl. 40): S23–7.Google Scholar
  4. 4.
    Editorial. Quality of life and clinical trials. Lancet 1995; 346 (8966): 1–2Google Scholar
  5. 5.
    Medical Research Council. Advice to applicants of clinical trial proposal, July 1993.Google Scholar
  6. 6.
    Evans RW, Manninen DL, Garrison LP et al. The quality of life of patients with end-stage renal failure. N Engl J Med 1985; 312: 553–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Evans RW. Quality of life assessment and the treatment of end-stage renal disease. Transplant Rev 1990; 4: 28–51.CrossRefGoogle Scholar
  8. 8.
    Mathers DF. Beyond survival. Dial Transplant 1980; 9: 657–61.Google Scholar
  9. 9.
    Hopkins A. How might measures of quality of life be useful to me as a Clinician? In: Hopkins A, ed. Measures of the Quality of Life. London: Royal College of Physicians of London Publications, 1992, pp. 1–13.Google Scholar
  10. 10.
    Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Fitzpatrik R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in healthcare. I: Applications and issues in assessment. Br Med J 1992; 305: 1074–7.CrossRefGoogle Scholar
  12. 12.
    Alexander JL, Willems EP. Quality of life: some measurement requirements. Arch Phys Med Rehabil 1981; 62: 261–5.PubMedGoogle Scholar
  13. 13.
    Stout J, Auer J. Rehabilitation and quality of life on CAPD. In: Gokal R, ed. Continuous Ambulatory Peritoneal Dialysis. Edinburgh: Churchill Livingstone, 1986, pp. 327–48.Google Scholar
  14. 14.
    Churchill DN. The effect of treatment modality on the quality of life for patients with end stage renal disease. Adv Petit Dial 1988; 8: 63–5.Google Scholar
  15. 15.
    Patrick DL, Erickson P. Health Status and Health Policy. Allocating Resources to Health Care. Oxford: Oxford University Press, 1993.Google Scholar
  16. 16.
    Hopkins A. Measuring the Quality of Medical Care. London: Royal College of Physicians of London Publications, 1990.Google Scholar
  17. 17.
    Black D. Ethical issues arising from measures of the Quality of Life. In: Hopkins A, ed. Measures of the Quality of Life. London: Royal College of Physicians of London Publications, 1992, pp. 121–9.Google Scholar
  18. 18.
    Black D. Paying for health. J Med Ethics 1991; 17: 117–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Dew MA, Simmons EG. The advantages of multiple measures of the Quality of Life. Scand J Urol Nephrol 1990; (suppl. 131 ): 23–30.Google Scholar
  20. 20.
    Meenan R, Gertman P, Mason J, Dunaif R. The arthritis impact measurement scales: further investigations of a Health Status instrument. Arch Rheum 1982; 19: 1048–53.CrossRefGoogle Scholar
  21. 21.
    Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II: Design, analysis, and interpretation. Br Med J 1992; 305: 1145–48.CrossRefGoogle Scholar
  22. 22.
    Bergner M, Bobbert R, Carter W, Gibson B. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805.PubMedCrossRefGoogle Scholar
  23. 23.
    Hunt S, McEwen J, McKenna S. Measuring Health Status. London: Croom Helm, 1986.Google Scholar
  24. 24.
    Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): 1. Conceptual framework and item selection. Med Care 1992; 30: 473–83.PubMedCrossRefGoogle Scholar
  25. 25.
    Spitzer W, Dobson A, Hall J et al. Measuring the Quality of Life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981; 34: 585–97.PubMedCrossRefGoogle Scholar
  26. 26.
    Churchill DN, Torrance GW, Taylor DE et al. Measurements of Quality of Life in end-stage renal failure. The time trade-off approach. Clin Invest Med 1987; 10: 14–27.PubMedGoogle Scholar
  27. 27.
    Cox D, Fitzpatrick R, Fletcher A et al. Quality of Life assessment: can we keep it simple? J R Stat Soc, Series A 1992; 155: 353–92.Google Scholar
  28. 28.
    Lomas J, Pickard L, Mohide A. Patients versus clinician item generation for Quality of Life measures. Med Care 1987; 25: 764–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Anderson R, Bury M. Living with Chronic Illness: the experience of patients and their families. London: Unwin, Hyman, 1988.Google Scholar
  30. 30.
    Guyatt G, Bernan L, Townsend M, Pingsey SO, Chambers LW. A measure of Quality of Life for clinical trials in chronic lung disease. Thorax 1987; 42: 773–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Stewart A, Greenfield S, Hays R et al. Functional status and well-being of patients with chronic conditions. JAMA 1989; 262: 907–13.PubMedCrossRefGoogle Scholar
  32. 32.
    Jenkinson C, Fitzpatrick R. Measurements of health status in patients with chronic illness: comparison of the Nottingham Health Profile and the general health questionnaire. Fam Pract 1990; 7: 121–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Patrick D, Deyo R. Generic and disease specific measures in assessing health status and quality of life. Med Care 1989; 27: S217–32.PubMedCrossRefGoogle Scholar
  34. 34.
    Guyatt G, Walter S, Norman G. Measuring changes over time: assessing the usefulness of evaluation instruments. J Chron Dis 1987; 40: 171–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Tugwell P, Bombardier C, Buchanan W et al. Methotrexate in rheumatoid arthritis: impact on Quality of Life assessed by traditional standard item and individual patient preference health status questionnaire. Arch Intern Med 1990; 150: 59–62.PubMedCrossRefGoogle Scholar
  36. 36.
    Deniston OL, Carpenter-Alting P, Kneisly J, Hawthorne M, Port FK. Assessment of Quality of Life in end-stage renal disease. Health Sery Res 1989; 24: 555–78.Google Scholar
  37. 37.
    Evans RW. Recombinant human erythropoietin and the Quality of Life of end-stage renal disease patients: a comparative analysis. Am J Kidney Dis 1991; 18 (suppl. 1): 62–70.PubMedGoogle Scholar
  38. 38.
    McClennan WM, Anson C, Birkeli K, Tuttle E. Functional status and Quality of Life. Predictors of early mortality among patients entering treatment for end-stage renal disease. J Clin Epidemiol 1991; 44: 83–9.CrossRefGoogle Scholar
  39. 39.
    Hart LG, Evans RW. The functional status of ESRD patients as measured by the sickness impact profile. J Chron Dis 1987; 40 (suppl. 1): S117–30.CrossRefGoogle Scholar
  40. 40.
    Meyer KB, Espindle DM, DeGiacomo JM et al. Monitoring dialysis patients’ health status. Am J Kidney Dis 1994; 24: 267–79.PubMedGoogle Scholar
  41. 41.
    Jenkinson C, Lawrence K, McWhinnie D, Gordon J. Sensitivity to changes of health status measures in a randomozed controlled trial: comparison of the COOP charts and the SF-36. Qual Lif Res 1995; 4; 47–52.CrossRefGoogle Scholar
  42. 42.
    Hemingway H, Stafford M, Stansfeld S, Shipley M, Marmot M. Is the SF-36 a valid measure of change in population health? Results from the Whitehall II study. Br Med J 1997; 315: 1273–9.CrossRefGoogle Scholar
  43. 43.
    Devins GM, Binik YM, Mandin H et al. The Kidney Diease Questionnaire: a test for measuring patient knowledge about end-stage renal disease. J Clin Epidemiol 1990; 43: 297–307.PubMedCrossRefGoogle Scholar
  44. 44.
    Laupacis A, Muirhead N, Keown P, Wong C. A disease specific questionnaire for assessing quality of life in patients on haemodialysis. Nephron 1992; 60: 302–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Laupacis A, Wong C, Churchill D and the Canadian Erythropoitin Study Group. The use of generic and specific quality of life measures in haemodialysis patients treated with erythropoietinn. Control Clin Trials 1991; 12: 168–79S.CrossRefGoogle Scholar
  46. 46.
    Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the Kidney Disease Quality of Life (KDQOL) Instrument. Qual Life Res 1994; 3: 329–38.PubMedCrossRefGoogle Scholar
  47. 47.
    Hays RD, Kallich JD, Mapes DL, Coons SJ, Amin N, Carter WB. Kidney Disease Quality of Life Short Form (KDQOL-SF), Version 1.2: a manual for use and scoring. P-7928, Santa Monica, CA: Rand, 1995.Google Scholar
  48. 48.
    KDQOL Newsletter 1997; 3: 1–8.Google Scholar
  49. 49.
    Parfrey PS, Vavasour HM, Bullock M et al. Development of a health questionnaire specific for ESRD. Nephron 1989; 52: 20–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Churchill DN, Wallace JE, Ludwin D et al. A comparison of evaluative indices of quality of life and cognitive function in haemodialysis patients. Control Clin Trials 1991; 12: 159–67.CrossRefGoogle Scholar
  51. 51.
    Bradley C. Design of a renal-dependent individualised quality of life questionnaire. Adv Perit Dial 1997; 13: 116–20.PubMedGoogle Scholar
  52. 52.
    Salek MS, Reakes AM. Quality of life assessment in end-stage renal disease using a renal-specific quality of life profile (RQLP): a practicality and validation study. Report 11994, University of Wales, Cardiff.Google Scholar
  53. 53.
    Salek MS. Quality of life assessment in patients on peritoneal dialysis; a review of the state of the art. Perit Dial Int 1996; 16 (suppl. 1): S398–401.PubMedGoogle Scholar
  54. 54.
    McKevitt P 1980. Support and support systems in dialysis. Dial Transplant 1980; 9: 980–1.Google Scholar
  55. 55.
    Perras SP, Zappacosta. AR. Identifying candidates for CAPD. Dial Transplant 1981; 10: 108–12.Google Scholar
  56. 56.
    DeNour AK. Medical staff’s attitude and patient rehabilitation. Proc EDTA 1980; 17: 520–3.Google Scholar
  57. 57.
    McKevitt P. Support in home and self-care. Dial Transplant 1980; 9: 1097–100.Google Scholar
  58. 58.
    Burton H, DeNour DK, Cowley JA, Wells CA, Wai L. Comparison of psychological adjustment to CAPD and home haemodialysis. Perit Dial Bull 1982; 2: 72–86.Google Scholar
  59. 59.
    Auer J. Quality of Life in CAPD related to sex and age: a comparison with haemodialysis. Proc EDTNA 1981; 9: 204–10.Google Scholar
  60. 60.
    Rasgon SA, Chemleski BL, Ho S et al. Benefits of a multidisciplinary predialysis program in maintaining employment among patients on home dialysis. Adv Perit Dial 1996; 12: 132–5.PubMedGoogle Scholar
  61. 61.
    Sesso R, Yoshihiro MM. Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 2111–16.PubMedCrossRefGoogle Scholar
  62. 62.
    deWardener HE. Some ethical and economic problems associated with intermittent haemodialysis. In: Wolstenholme GEW, O’Conner M, eds. Ethics in Medicine. Boston: Luth Brown, 1966, pp. 104–26.Google Scholar
  63. T. Apostolou and R. Gokal 733Google Scholar
  64. 63.
    Evans RW, Blagg CR, Bryan FA. Implications for healthcare policy. A social and demographic profile of haemodialysis patients in the United States. JAMA 1981; 245: 487–92.PubMedCrossRefGoogle Scholar
  65. 64.
    Hagberg B, Malnquist AA. A prospective study of patients on chronic haemodialysis. Pretreatment of psychiatric and psychological variables predicting outcome. J Psychosom Res 1974; 18: 315–22.PubMedCrossRefGoogle Scholar
  66. 65.
    DeNour AK, Czaczkes JW. Adjustment to chronic haemodialysis. Israel J Med Sci 1974; 10: 498–505.Google Scholar
  67. 66.
    Gutman RA, Stead WW, Robinson RR et al. Physical activity and employment status of patients on maintenance haemodialysis. N Engl J Med 1981; 304: 309–13.PubMedCrossRefGoogle Scholar
  68. 67.
    Rennie D. Renal rehabilitation–where are the data? N Engl J Med 1981; 304: 351–3.PubMedCrossRefGoogle Scholar
  69. 68.
    Evans RW, Manninen DL, Garrison LP et al. Special reports: Fundings from the National Kidney Dialysis and Kidney Transplantation Study. HCFA Publ No. 3230, Baltimore, MD: Health Care Financing Administration, 1987.Google Scholar
  70. 69.
    National ESRD Patient Rehabilitation Task Force: Final report of the National ESRD Patient Rehabilitation Task Force. Transmitted by RA Guttman, June 1980.Google Scholar
  71. 70.
    Auer J, Simon G, Oliver DO, Anastassiades E, Stephens J, Gokal R. Improvements in quality of life on CAPD patients treated with subcutaneously administered erythropoietin for anaemia. Petit Dial Int 1992; 12: 40–2.Google Scholar
  72. 71.
    Deniiston QL, Luscombe FA, Buesching DP, Richer RE, Spinowitz BS. Effect of long term erythropoietin beta therapy on the quality of life of haemodialysis patients. Am Soc Artif Organs Transplant 1990; 36: M157–60.Google Scholar
  73. 72.
    Wolcott DL, Marsh JT, LaRue A, Carr C, Nissenson AR. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic haemodialysis patients. Am J Kidney Dis 1989; 14 (suppl. 1): 14–18.Google Scholar
  74. 73.
    Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990; 300: 573–8.CrossRefGoogle Scholar
  75. 74.
    Evans RW. Recombinant human erythropoietin and the quality of life of endstage renal disease patients: a comparative analysis. Am J Kidney Dis 1991; 18 (suppl. 1): 62–70.PubMedGoogle Scholar
  76. 75.
    Evans RW, Rader B, Manninen DL. The quality of life of haemodialysis recipients treated with recombinant human erythropoietin. Cooperative multicentre EPO clinical trial group. JAMA 1990; 263: 825–30.PubMedCrossRefGoogle Scholar
  77. 76.
    Nissenson AR. National cooperative rHuEPO study in patients with CRF. A phase IV multicentre study. Am J Kidney Dis 1991; 18 (suppl. 1): 24–33.PubMedGoogle Scholar
  78. 77.
    Beusterien KM, Nissenson AR, Port K, Kelly M, Steinwald B, Ware JE, Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996; 7: 763–73.PubMedGoogle Scholar
  79. 78.
    Klahr S. Rationing of health care and the endstage renal disease programme. Am J Kidney Dis 1990; 16: 392–5.PubMedGoogle Scholar
  80. 79.
    Ari D, Held PJ, Pauly MV. The Medicare cost of renal dialysis. Med Care 1992; 30: 879–91.CrossRefGoogle Scholar
  81. 80.
    Friedman EA. Nephrology and the rationing of healthcare. Contrib Nephrol 1993; 102: 200–36.Google Scholar
  82. 81.
    Maiorca R, Cancarini GC, Oreopoulos DG. PD or not PD? That is the question. Am J Kidney Dis 1997; 30: 445–7.PubMedCrossRefGoogle Scholar
  83. 82.
    Morris PLP, Jones B. Transplantation versus dialysis: a study of Quality of Life. Transplant Proc 1988; 20: 23–6.PubMedGoogle Scholar
  84. 83.
    Auer J, Gokal R, Stout JP et al. The Oxford/Manchester study of dialysis patients. Scand J Urol Nephrol 1990; (suppl.) 131: 31–7.Google Scholar
  85. 84.
    Stout J. How does dialysis affect the lifestyle of renal patients? A comparative study between CAPD and HD. EDTNA J 1988; 9; 11–2.Google Scholar
  86. 85.
    Stout J, Gokal R, Hillier V et al. Quality of Life of high risk and elderly dialysis patients in the UK. Dial Transplant 1987; 16: 674–7.Google Scholar
  87. 86.
    Simmons RG, Anderson CR, Abress LK. Quality of Life and rehabilitation differences among four ESRD therapy groups. Scand J Urol Nephrol 1990; (suppl.) 131: 7–22.Google Scholar
  88. 87.
    Wolcott DL, Nissenson AR. Quality of Life in chronic dialysis patients: a critical comparison of CAPD and HD. Am J Kidney Dis 1988; 11: 402–12.PubMedGoogle Scholar
  89. 88.
    Nissenson AR, Maida CA, Katz AH et al. Psychological adaptation of CAPD and centre haemodialysis patients. Adv Petit Dial 1986; 4: 47–56.Google Scholar
  90. 89.
    Bremmer BA, McCauley CR, Wrona RM, Johnston JP. Quality of life in endstage renal disease: a re-examination. Am J Kidney Dis 1989; 13; 200–9.Google Scholar
  91. 90.
    Tucker CM, Ziller RC, Smith WR, Mars DR, Coone MP. Quality of Life of patients on incentre haemodialysis versus CAPD. Petit Dial Int 1991; 11: 341–6.Google Scholar
  92. 91.
    Muthny FA, Koch K. Quality of Life of patients with end-stage renal failure. In: La Graca G, Olivares J, Feriani M, Passlick-Deitjen J, eds. CAPD–A Decade of Experience. Basel: Karger 1991, Vol. 89, pp. 265–73.Google Scholar
  93. 92.
    Kalman TP, Wilson PG, Kilman CM. Psychiatric morbidity in longterm renal transplant recipients and patients undergoing haemodialysis. JAMA 1983; 250: 55–8.PubMedCrossRefGoogle Scholar
  94. 93.
    Gudex CM. Health-related quality of life in endstage renal failure. Qual Life Res 1995; 4; 359–66.PubMedCrossRefGoogle Scholar
  95. 94.
    Rosser R, Kind P. A scale of valuations of State of Illness: is there a social consensus? Int J Epidemiol 1978; 7: 347–58.PubMedCrossRefGoogle Scholar
  96. 95.
    Gokal R, Figueras M, 011e A, Rovira J, Badia X. Outcomes in peritoneal dialysis and haemodialysis–a comparative assessment of survival and quality of life. Nephrol Dial Transplant 1999; 14 (suppl. 6): 24–30.PubMedCrossRefGoogle Scholar
  97. 96.
    Parfrey PS, Vavasour HM, Henry S et al. Clinical features and severity of non specific symptoms in dialysis patients. Nephron 1988; 50: 121–8.PubMedCrossRefGoogle Scholar
  98. 97.
    Moreno F, Lopez-Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F (on behalf of the Spanish Cooperative Renal Patients Quality of Life Study Group). Quality of life in dialysis patients. A Spanish multicentre study. Nephrol Dial Transplant 1996; 11 (suppl. 2): 125–9.PubMedCrossRefGoogle Scholar
  99. 98.
    Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis; self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 1997; 29: 584–92.PubMedCrossRefGoogle Scholar
  100. 99.
    Carmichael P, Popola J, Carmichael AR, Prosser DI, Stevens PE. Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire. J Am Soc Nephrol 1998; 9: 142A (abstract).Google Scholar
  101. 100.
    Walters BAJ, Bander SJ, Lin S, DiDominic V. Quality of life comparison between HD, HomeHD, CAPD and CCPD using the SF-36 quality of life instrument. J Am Soc Nephrol 1998; 9: 240A (abstract).Google Scholar
  102. 101.
    Russell JD, Beecroft ML, Ludwen D, Churchill DN. The quality of life measures in renal transplantation–a prospective study. Transplantation 1992; 54: 656–60.PubMedCrossRefGoogle Scholar
  103. 102.
    Doyle CL, Flannigan J, Mabe C. Tidal peritoneal dialysis vs CAPD Children’s preference. ANNA J 1992; 19: 249–54.PubMedGoogle Scholar
  104. 103.
    Roscoe JM, Smith CF, Wiliams EA et al. Medical and social outcome in adolescents with endstage renal failure. Kidney Int 1991; 40: 948–53.PubMedCrossRefGoogle Scholar
  105. 104.
    Sandroni S, Arona N, Vidrene L, Moles K. Feasibility of incentre staff assisted cycler dialysis. Adv Petit Dial 1990; 6: 76–8.Google Scholar
  106. 105.
    Kutner NG, Brogan DJ. Assisted survival, ageing and rehabilitation needs: comparison in older diallysis patients and age matched peers. Arch Phys Med Rehabil 1992; 73: 309–15.PubMedCrossRefGoogle Scholar
  107. 106.
    Avram MR, Pena C, Burrel D, Antignani A, Avram MM. Haemodialysis and the elderly patients: potential advantages as to quality of life. Urea generation, serum creatinine and less interdialysate weight gain. Am J Kidney Dis 1990; 16: 342–5.PubMedGoogle Scholar
  108. 107.
    Churchill D, Morgan J, Torrance G. Quality of life in end-stage renal disease. Petit Dial Bull 1984; 4: 20–3.Google Scholar
  109. 108.
    Revicki D. Relationship between Health Utility and psychometric health status measures. Med Care 1992; 30: MS274–82.Google Scholar
  110. 109.
    Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patient’s well-being and consequent effects on a cost-effectiveness analysis. J Clin Epidemiol 1992; 5: 505–12.CrossRefGoogle Scholar
  111. 110.
    Busschbach JJ, Hessing DJ, de Charro FT. The utility of health at different stages in life: a quantitative approach. Soc Sci Med 1993; 37: 153–8.PubMedCrossRefGoogle Scholar
  112. 111.
    Evans RW, Blagg C, Bryan FA. Implications for health care policy: a social and demographic profile of haemodialysis patients in the United States. JAMA 1981; 245: 487–91.PubMedCrossRefGoogle Scholar
  113. 112.
    Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. N Engl J Med 1981; 304: 309–13.PubMedCrossRefGoogle Scholar
  114. 113.
    Peters VJ, Hazel LA, Finkel P, Coils J. Rehabilitation experience of patients receiving dialysis. ANNA 1994; 21: 419–26.Google Scholar
  115. 114.
    Ifudu O, Paul H, Mayers J et al. Pervasive failed rehabilitation in center-based maintenance haemodialysis patients. Am J Kidney Dis 1994; 23: 394–400.PubMedGoogle Scholar
  116. 115.
    Life Option Rehabilitation Advisory Council. Renal Rehabilitation: Bridging the Barriers. Madison, WI: Medical Education Institute, Inc., 1994.Google Scholar
  117. 116.
    Fragola JA, Grube S, VanBlock L, Bourke E. Multicentre study of physical activity and employment status of CAPD patients in the United States. Proc EDTA 1983; 20: 243–9.Google Scholar
  118. 117.
    Julius M, Kneisley J, Carpentier-Alting P, Hawthorne V, Wolfe R, Port K. A comparison of employment rates of patients treated with CAPD vs incentre haemodialysis. Arch Intern Med 1989; 149: 839–42.PubMedCrossRefGoogle Scholar
  119. 118.
    Seedat YK, McIntosh CG, Subban JV. Quality of life for patients in an endstage renal disease programme. S Afr Med J 1987; 71: 500–4.PubMedGoogle Scholar
  120. 119.
    Simmons RG, Abress L. Quality of Life issues for endstage renal disease patients. Am J Kidney Dis 1990; 15: 201–8.PubMedGoogle Scholar
  121. 120.
    Goldberg AP, Geldman EM, Hagberg JM et al. Therapeutic benefits of exercise training for haemodialysis patients. Kidney Int 1983; 24 (suppl.): 303–9.CrossRefGoogle Scholar
  122. 121.
    Ross DL, Grabeau GM, Smith S, Seymour M, Knierim N, Pitetti KH. Efficacy of exercise for endstage renal disease patients immediately following high efficiency haemodialysis: a pilot study. Am J Nephrol 1989; 9: 376–83.PubMedCrossRefGoogle Scholar
  123. 122.
    Kouidi E, Iacovides A, Iordanidis P et al. Exercise renal rehabilitation program: psychosocial effects. Nephron 1997; 77: 152–8.PubMedCrossRefGoogle Scholar
  124. 123.
    Oberley ET, Compton A. Nursing interventions for rehabilitating renal patients. ANNA J 1994; 21: 407–11.PubMedGoogle Scholar
  125. 124.
    Gokal R, Uttley L. A collection of problems in CAPD. Adv Petit Dial 1989; 5: 76–80.Google Scholar
  126. 125.
    Stout JP, Auer J, Kincey J et al. Sexual and marital relationships and dialysis patients’ viewpoint. Petit Dial Bull 1987; 7: 97–101.Google Scholar
  127. 126.
    Steele TE, Wuerth D, Finkelstein S et al. Sexual experience of the CAPD patient. J Am Soc Nephrol 1996; 7: 1165–8.PubMedGoogle Scholar
  128. 127.
    Soskolne V, DeNour AK. Psychosocial adjustment of home HD, CAPD and hospital diaysis patients and their spouses. Nephron 1987; 47: 266–73.PubMedCrossRefGoogle Scholar
  129. 128.
    Uttley L. Treatment of sexual dysfunction. Petit Dial Int 1996; 16 (suppl. 1): 5402–5.Google Scholar
  130. 129.
    Sensky T. Psychosomatic aspects of endstage renal failure. Psychother Psychosom 1993; 59: 56–68.PubMedCrossRefGoogle Scholar
  131. 130.
    Kimmel PL, Peterson RA, Simmens SJ et al. Psychosocial factors, behavioral compliance and survival in urban haemodialysis patients. Kidney Int 1998; 54: 245–54.PubMedCrossRefGoogle Scholar
  132. 131.
    DeNour AK, Czaczkes JW. Personality factors in chronic haemodialysis patients causing non-compliance with medical regime. Psychosom Med 1972; 34: 333–44.Google Scholar
  133. 132.
    Wells KB, Stewart A, Hays RD et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989; 262: 914–19.PubMedCrossRefGoogle Scholar
  134. 133.
    Shidler NR, Peterson RA, Kimmel PL. Quality of life and psychosocial relationships in patients with chronic renal insufficiency. Am J Kidney Dis 1998; 32: 557–66.PubMedCrossRefGoogle Scholar
  135. 134.
    Juergensen PH, Wuerth DB, Juergensen DM et al. Psychosocial factors and clinical outcome on CAPD. Adv Petit Dial 1997; 13: 121–4.Google Scholar
  136. 135.
    Bihl MA, Ferrans CE, Powers MJ. Comparing stressors and quality of llife of dialysis patients. ANNA J 1988; 15: 27–36.PubMedGoogle Scholar
  137. 136.
    Eichel CJ. Stress and coping in patients on CAPD compared to haemodialysis patients. ANNA J 1986; 13: 9–73.PubMedGoogle Scholar
  138. 137.
    Fuchs J, Schreiber M. Patients perceptive of CAPD and haemodialysis stressors. ANNA J; 1988; 15: 282–300.PubMedGoogle Scholar
  139. 138.
    Hoothay F, Leary EM. Life satisfaction and coping of diabetic haemodialysis patients. ANNA J 1990; 17: 361–5.PubMedGoogle Scholar
  140. 139.
    Agodoa LY, Eggers PW. Renal replacement therapy in the United States: data from the United States Renal Data System. Am J Kidney Dis 1995; 25: 119–33.PubMedCrossRefGoogle Scholar
  141. 140.
    Sessa A. When dialysis becomes worse than death. Nephrol Dial Transplant 1995; 10: 1128–30.PubMedGoogle Scholar
  142. 141.
    Cohen LM, McCue JD, Germain M, Kjellstrand CM. Dialysis discontinuation. A `good’ death? Arch Intern Med 1995; 155: 42–7.PubMedCrossRefGoogle Scholar
  143. 142.
    Weisman AD. On Dying and Denying: a psychiatric study of terminality. New York: Behavioral Publications Inc., 1972, pp. 32–41.Google Scholar
  144. 143.
    Moss AH, Stocking CB, Sachs GA, Siegler M. Variation in the attitudes of dialysis unit medical directors towards decisions to withhold and withdraw dialysis. J Am Soc Nephrol 1993; 4: 229–34.PubMedGoogle Scholar
  145. 144.
    Rutecki GW, Cugino A, Jarloura D, Kilner JF, Whittier FC. Nephrologists’ subjective attitudes towards end-of-life issues and the conduct of terminal care. Clin Nephrol 1997; 48: 173–80.PubMedGoogle Scholar
  146. 145.
    Carlson RW. Editorial. Quality of death after discontinuation of dialysis. Arch Intern Med 1995; 155: 13.PubMedCrossRefGoogle Scholar
  147. 146.
    Auer J. Dialysis withdrawal. Br J Renal Med 1997; 1: 18–20.Google Scholar
  148. 147.
    Sekkarie MA, Moss AH. Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status. Am J Kidney Dis 1998; 31: 464–72.PubMedCrossRefGoogle Scholar
  149. 148.
    Moss AH. Managing conflict with families over dialysis discontinuation. Am J Kidney Dis 1998; 31: 868–83.PubMedCrossRefGoogle Scholar
  150. 149.
    Oreopoulos DG. Withdrawal from dialysis: when letting die is better than helping to live. Lancet 1995; 346: 3–4.PubMedCrossRefGoogle Scholar
  151. 150.
    Council on Ethical and Judicial Affairs, American Medical Association: decisions near the end of life. JAMA 1992; 267: 2229–33.CrossRefGoogle Scholar
  152. 151.
    Angel M. Editorial, Euthanasia in Netherlands. Bad news or good news? N Engl J Med, 1996; 335: 22.Google Scholar
  153. 152.
    Annual data report of US Renal Data System. Incidence and prevalence of ESRD, 1998, pp. 23–35.Google Scholar
  154. 153.
    Annual data report of US Renal Data System. Incidence and prevalence of ESRD, 1998, pp. 121–32.Google Scholar
  155. 154.
    Schleifer CR. Nursing home dialysis: can we meet the challenge? Petit Dial Int 1997; 17: 234–5.Google Scholar
  156. 155.
    Anderson J, Kraus J, Sturgeon D. Incidence, prevalence, and outcomes of endstage renal disease patients placed in nursing homes. Am J Kidney Dis 1993; 21: 619–27.PubMedGoogle Scholar
  157. 156.
    Anderson JE. Ten years’ experience with CAPD in a nursing home setting. Petit Dial Int 1997; 17: 255–61.Google Scholar
  158. 157.
    Jassal SV, Brissenden JE, Roscoe JM. Specialized chronic care for dialysis patients–a five year study. Clin Nephrol 1998; 50: 84–9.PubMedGoogle Scholar
  159. 158.
    Wicks MN, Milstead EJ, Hathaway DK, Cetingok M. Subjective burden and quality of life in family caregivers of patients with endstage renal disease. ANNA J 1997; 24: 527–38.PubMedGoogle Scholar
  160. 159.
    Campbell AR. Family caregivers: caring for ageing endstage renal disease partners. Adv Renal Replace Ther 1998; 5: 98–108.Google Scholar
  161. 160.
    Brunier GM, McKeever PT. The impact of home dialysis on the family: Literature review. ANNA J 1993; 20: 653–9.PubMedGoogle Scholar
  162. 161.
    Thompson JEH, Doll W. The burden of families coping with the mentally ill: an invisible family crisis. Fam Rel 1982; 31: 379–88.CrossRefGoogle Scholar
  163. 162.
    LoGiudice D, Kerse N, Brown K et al. The psychosocial health status of carers of persons with dementia: a comparison with the chronically ill. Qual Life Res 1998; 7: 345–51.PubMedCrossRefGoogle Scholar
  164. 163.
    Watson AR. Stress and burden of care in families with children commencing renal replacement therapy. Adv Petit Dial 1997; 13: 300–4.Google Scholar
  165. 164.
    Dunn SA, Bonner PN, Lewis SL, Meize-Grochowski A. Quality of life for spouses of CAPD patients. ANNA J 1994; 21: 237–47.PubMedGoogle Scholar
  166. 165.
    Watson AR. Home health and respite care. Petit Dial Int 1996; 16 (suppl. 1): S551–3.Google Scholar
  167. 166.
    Boen ST, Molinari AS, Dillar DH, Scribner BH. Periodic peritoneal dialysis in the management of chronic uraemia. Trans Am Soc Artif Intern Organs 1962; 8: 256–62.CrossRefGoogle Scholar
  168. 167.
    Lasker N, McCauley EP, Passeroti CT. Chronic peritoneal dialysis. Trans Am Soc Artif Intern Organs 1966; 12: 94–7.PubMedGoogle Scholar
  169. 168.
    Diaz-Buxo JA, Suki WN. Automated Peritoneal Dialysis. In: Gokal R, Nolph KD, eds. Textbook of Peritoneal Dialysis. Dordrecht, Kluwer Academic Publishers, 1994, pp. 399–418.CrossRefGoogle Scholar
  170. 169.
    KL, Cox P. Continuous cyclic peritoneal dialysis: a viable option in the treatment of chronic renal failure. Trans Am Soc Artif Intern Organs 1981; 27: 51–3.Google Scholar
  171. 170.
    Misra M, Nolph KD, Khanna R. Will automated peritoneal dialysis be the answer? Petit Dial Int 1997; 17: 435–9.Google Scholar
  172. 171.
    Williams P, Cartmel L, Holis J. The role of automated peritoneal dialysis (APD) in an integrated dialysis programme. Br Med J 1997; 53: 697–705.Google Scholar
  173. 172.
    Wrenger E, Krautzig S, Brunkhorst R. Adequacy and quality of life with automated peritoneal dialysis Petit Dial Int 1996; 16 (suppl. 1): S153–7.Google Scholar
  174. 173.
    McComb J, Morton R, Singer MA, Hopman WM, MacKenzie T. Impact of portable APD on patient perception of health related quality of life. Adv Petit Dial 1997; 13: 137–40.Google Scholar
  175. 174.
    Wrenger E, Krautzig S, Brunkhorst R. Adequacy and quality of life with automated peritoneal dialysis. Petit Dial Int 1996; 16 (suppl. 1): S153–7.Google Scholar
  176. 175.
    Nissenson AR. Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 1989; 9 (suppl. 2): 25–31.PubMedGoogle Scholar
  177. 176.
    Levin NW, Lazarus M, Nissenson AR, for the National Cooperative rHu Erythropoietin Study Group: National Cooperative Hu Erythropoietin Study in patients with chronic renal failure–an interim report. Am J Kidney Dis 1993; 22 (suppl. 1): 3–12.PubMedGoogle Scholar
  178. 177.
    Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low haematocrit values in patients with cardiac disease who are receiving haemodialysis and erythropoietin. N Engl J Med 1998; 339: 584–90.PubMedCrossRefGoogle Scholar
  179. 178.
    Adamson JW, Eschbach JW. Editorial. Erythropoietin for endstage renal disease. N Engl J Med 1998; 339: 625–7.PubMedCrossRefGoogle Scholar
  180. 179.
    Macdougal IC, Ritz E. The normal haematocrit trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant 1998; 13: 3030–3.CrossRefGoogle Scholar
  181. 180.
    Eschbach HW, Abdulhadi MH, Brown JK et al. Recombinant human erythropoietin in anaemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992–1000.PubMedCrossRefGoogle Scholar
  182. 181.
    Beusterien KM, Nissenson AR, Port FK, Kely M, Steinwald B, Ware JE Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996; 7: 763–73.PubMedGoogle Scholar
  183. 182.
    Marsh JT, Brown WS, Wolcott D et al. RHuEPO treatment improves brain and cognitive function of anaemic dialysis patients. Kidney Int 1991; 39: 155–63.PubMedCrossRefGoogle Scholar
  184. 183.
    Nissenson AR, Prichard SS, Cheng IKP et al. Non medical factors that impact on ESRD modality selection. Kidney Int 1993; 43 (suppl. 40): S120–7.Google Scholar
  185. 184.
    Porter GA, Lowson L, Buss J. Bias in selecting treatment for endstage renal disease. Kidney Int 1985; 28 (suppl. 17): S34–7.Google Scholar
  186. 185.
    Parfrey PS, Vavasour HM, Gault MH. A prospective study of health status in dialysis and transplant patients. Transplant Proc 1988; 20: 1231–2.PubMedGoogle Scholar
  187. 186.
    Gokal R, Jakubowksi C, King J et al. Outcome in patients in CAPD and haemodialysis: 4 year analysis of a prospective multicentre study. Lancet 1987; 2: 1105–9.PubMedCrossRefGoogle Scholar
  188. 187.
    Serles KD, Blagg CR, Nolph KD, Vonesh EF, Shapiro F. Comparison of patient and technique survival in CAPD and haemodialysis: a multicentre study. Petit Dial Int 1990; 10: 15–19.Google Scholar
  189. 188.
    Kutner NG, Brogan D, Kutner MH. Endstage renal disease treatment modality and patients Quality of Life. Am J Nephrol 1986; 6: 396–402.PubMedCrossRefGoogle Scholar
  190. 189.
    Oldenburg B, MacDonald GS, Perkins RJ. Prediction of quality of life in a cohort of endstage renal disease patients. J Clin Epidemiol 1988; 41: 555–64.PubMedCrossRefGoogle Scholar
  191. 190.
    Rozembaum EA, Pliskin JS, Barnoon S, Chaimovitz C. Comparative study of costs and quality of life of CAPD and hemodialysis patients in Israel. Israel J Med Sc 1985; 21: 335–9.Google Scholar
  192. 191.
    Hart LG, Evans RW. The functional status of ESRD patients as measured by the sickness impact profile. J Chron Dis 1987; 40 (suppl. 1): S117–30.CrossRefGoogle Scholar
  193. 192.
    Julius M, Hawthorne VM, Carpentier-Alting P, Kneisley J, Wolfe RA, Port FK. Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates. Am J Kidney Dis 1989; 13: 61–9.PubMedGoogle Scholar
  194. 193.
    Morris PLB, Jones B. Life satisfaction across treatment methods for patients with end-stage renal failure. Med J Aust 1989; 150: 428–32.PubMedGoogle Scholar
  195. 194.
    Tucker CM, Ziller RC, Smith WR, Mars DR, Coons MP. Quality of life in patients on in-centre hemodialysis versus CAPD. Petit Dial Int 1991; 11: 341–6.Google Scholar
  196. 195.
    Griffin KW, Wadwa NK, Friend R et al. Comparison of quality of life in hemodialysis and peritoneal dialysis patients. Adv Petit Dial 1994; 10: 104–8.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2000

Authors and Affiliations

  • T. Apostolou
  • R. Gokal

There are no affiliations available

Personalised recommendations